Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland:

- NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV®)

- NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase®)

- NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal®)

The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV®/ Elaprase®/ Replagal®) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.